{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:02:39Z","timestamp":1781766159428,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001821","name":"Vienna Science and Technology Fund","doi-asserted-by":"publisher","award":["LS18-031"],"award-info":[{"award-number":["LS18-031"]}],"id":[{"id":"10.13039\/501100001821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ajt.2022.09.002","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T18:05:41Z","timestamp":1673460341000},"page":"84-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5049-2048","authenticated-orcid":false,"given":"Moritz","family":"Muckenhuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-922X","authenticated-orcid":false,"given":"Jasmin","family":"Mucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-401X","authenticated-orcid":false,"given":"Konstantinos","family":"Mengrelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-4308","authenticated-orcid":false,"given":"Christopher","family":"How","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4419-6282","authenticated-orcid":false,"given":"Roman","family":"Reindl-Schwaighofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-1795","authenticated-orcid":false,"given":"Andreas","family":"Heinzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-0077","authenticated-orcid":false,"given":"Verena","family":"Kainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3599-8099","authenticated-orcid":false,"given":"Nina","family":"Worel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8850-7874","authenticated-orcid":false,"given":"Gabriela","family":"Berlakovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2889-2533","authenticated-orcid":false,"given":"Matthias","family":"Edinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7544-6275","authenticated-orcid":false,"given":"Rainer","family":"Oberbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-2796","authenticated-orcid":false,"given":"Thomas","family":"Wekerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajt.2022.09.002_bib1","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2022.09.002_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"S\u00e1nchez-Fueyo","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2022.09.002_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A\u00a0pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ajt.2022.09.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2021.11.007","article-title":"Emerging strategies for treating autoimmune disorders with genetically modified Treg cells","volume":"149","author":"Boardman","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2022.09.002_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajt.2022.09.002_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3389\/fimmu.2020.01608","article-title":"The future of regulatory T cell therapy: promises and challenges of implementing CAR technology","volume":"11","author":"Mohseni","year":"2020","journal-title":"Front Immunol"},{"issue":"10237","key":"10.1016\/j.ajt.2022.09.002_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajt.2022.09.002_bib8","doi-asserted-by":"crossref","first-page":"m3734","DOI":"10.1136\/bmj.m3734","article-title":"Regulatory T cells for minimising immune suppression in kidney transplantation: phase I\/IIa clinical trial","volume":"371","author":"Roemhild","year":"2020","journal-title":"BMJ"},{"issue":"10084","key":"10.1016\/j.ajt.2022.09.002_bib9","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(17)31283-7","article-title":"Strategies for long-term preservation of kidney graft function","volume":"389","author":"Wekerle","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajt.2022.09.002_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1600-6143.2007.01829.x","article-title":"CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects","volume":"7","author":"Kang","year":"2007","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2022.09.002_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/15260","article-title":"Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance","volume":"5","author":"Wells","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.ajt.2022.09.002_bib12","article-title":"A\u00a0prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex001)","volume":"7","author":"Oberbauer","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajt.2022.09.002_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0966-3274(01)00048-X","article-title":"Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations","volume":"9","author":"Regan","year":"2001","journal-title":"Transpl Immunol"},{"issue":"7","key":"10.1016\/j.ajt.2022.09.002_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2-3","key":"10.1016\/j.ajt.2022.09.002_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.trim.2013.03.001","article-title":"Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial","volume":"28","author":"B\u00fcchler","year":"2013","journal-title":"Transpl Immunol"},{"issue":"7","key":"10.1016\/j.ajt.2022.09.002_bib16","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V91.7.2360","article-title":"Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins","volume":"91","author":"Genestier","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ajt.2022.09.002_bib17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","article-title":"Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells","volume":"104","author":"Hoffmann","year":"2004","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.ajt.2022.09.002_bib18","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ajt.2022.09.002_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/bio.2018.0032","article-title":"Usage data and scientific impact of the prospectively established fluid bioresources at the hospital-based MedUni Wien Biobank","volume":"16","author":"Haslacher","year":"2018","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.ajt.2022.09.002_bib20","article-title":"Treg therapies revisited: tolerance beyond deletion","volume":"11","author":"Pilat","year":"2020","journal-title":"Front Immunol"},{"issue":"7A","key":"10.1016\/j.ajt.2022.09.002_bib21","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1016\/S0041-1345(97)80006-1","article-title":"Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression","volume":"29","author":"Guttmann","year":"1997","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.ajt.2022.09.002_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-3274(99)80028-8","article-title":"Sensitization following thymoglobulin and atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group","volume":"7","author":"Regan","year":"1999","journal-title":"Transpl Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2022.09.002_bib23","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1172\/JCI82267","article-title":"Rabbit antithymocyte globulin\u2013induced serum sickness disease and human kidney graft survival","volume":"125","author":"Couvrat-Desvergnes","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.ajt.2022.09.002_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-8587(13)70065-2","article-title":"Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial","volume":"1","author":"Gitelman","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.ajt.2022.09.002_bib25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Low-dose anti-thymocyte globulin (ATG) preserves \u03b2-cell function and improves HbA1c in new-onset type 1 diabetes","volume":"41","author":"Haller","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajt.2022.09.002_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.843452","article-title":"Effects of reduced-dose anti-human T-lymphocyte globulin on overall and donor-specific T-cell repertoire reconstitution in sensitized kidney transplant recipients","volume":"13","author":"Aschauer","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2022.09.002_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2011.04.006","article-title":"A\u00a0central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity","volume":"34","author":"Li","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ajt.2022.09.002_bib28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.ajt.2022.09.002_bib29","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/ajt.13685","article-title":"Regulatory T cell infusion can enhance memory T cell and alloantibody responses in lymphodepleted nonhuman primate heart allograft recipients","volume":"16","author":"Ezzelarab","year":"2016","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2022.09.002_bib30","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/TP.0000000000003617","article-title":"Ex vivo expanded donor alloreactive regulatory T cells lose immunoregulatory, proliferation, and antiapoptotic markers after infusion into ATG-lymphodepleted, nonhuman primate heart allograft recipients","volume":"105","author":"Ezzelarab","year":"2021","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.ajt.2022.09.002_bib31","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41409-019-0505-5","article-title":"Effect of plasmapheresis on ATG (thymoglobulin) clearance prior to adoptive T cell transfer","volume":"54","author":"Zhang","year":"2019","journal-title":"Bone Marrow Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522292557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522292557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:34:03Z","timestamp":1761629643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522292557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1600613522292557"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2022.09.002","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}